Roche Pakistan Limited. is a pharmaceutical manufacturer registered with the Drug Regulatory Authority of Pakistan, holding 67 product registrations across 79 distinct molecules. Its portfolio is concentrated in Antineoplastics and Antivirals For Systemic Use. DRAP has issued 3 alerts involving its products.
Compiled from the DRAP registry, DRAP approved prices and DRAP alerts, with observed retail from DVAGO and Servaid. Data as of 2026-07-30.
Products by Roche
17 products matched in our catalogue — each with its observed price and DRAP approved ceiling.
DRAP sets a maximum price per registration and revises it only on application. In a market with high inflation, an old ceiling erodes margin in real terms.
This page is a summary. The full company brief adds every registration with its approved ceiling and approval date, per-molecule competitive position, price positioning against the category, and a launch shortlist built from the whitespace above.